Bristol-Myers Squibb Becomes Oversold |
January 21, 2017 | January 2017 Bond Updates |
Bristol-Myers Squibb Co. an even more interesting and timely stock to look at, is the fact that in trading on Friday, shares of BMY entered into oversold territory, changing hands as low as $49.62 per share. We define oversold territory using the Relative Strength Index |
View more at: http://www.forbes.com/sites/dividendchannel/2017/01/20/bristol-myers-squibb-becomes-oversold-3/ |
Related News |
|